Freya Biosciences

Healthcare & Life Sciences

Recent Finacing

Equity

Recent Raise

$11.8M

Freya Biosciences is a biotech company advancing women's reproductive health through the development of vaginal microbial immunotherapeutics for infertility associated with dysbiotic vaginal microbiota in patients undergoing assisted reproductive technology.

Total Funding

$49.8M

Headquarters

Copenhagen, Denmark

Founded

N/A

Website

freyabiosciences.com

Focus Areas

Biotech

Women's Reproductive Health

Clinical Development

Immunotherapeutic

Infertility Treatment

Multi-Omics Data Science

Investors